These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13711881)

  • 1. A second example of red cell polyagglutinability caused by the Tn antigen.
    van der HART ; MOES M; van LOGHEM J; ENNEKING JH; LEEKSMA CH
    Vox Sang; 1961 May; 6():358-61. PubMed ID: 13711881
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
    Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
    Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tn-polyagglutinability associated with acute myelomonocytic leukemia.
    Baldwin ML; Barrasso C; Ridolfi RL
    Am J Clin Pathol; 1979 Dec; 72(6):1024-7. PubMed ID: 293127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistent polyagglutinability of erythrocytes due to Tn antigen (author's transl)].
    Busová B; Piacková I
    Bratisl Lek Listy; 1977 Oct; 68(4):488-93. PubMed ID: 922527
    [No Abstract]   [Full Text] [Related]  

  • 5. Tn polyagglutinability occurring in a patient with B cell lymphoma.
    Wallner M; Waldner R
    Blut; 1985 Nov; 51(5):355-60. PubMed ID: 3933597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of sialosyl-Tn (NeuAc alpha 2----6GalNAc alpha 1----O-Ser/Thr) and Tn (GalNAc alpha 1----O-Ser/Thr) blood group antigens on Tn erythrocytes.
    Kjeldsen T; Hakomori S; Springer GF; Desai P; Harris T; Clausen H
    Vox Sang; 1989; 57(1):81-7. PubMed ID: 2800471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "New" lectins for the identification of erythrocyte cryptantigens and the classification of erythrocyte polyagglutinability: Medicago disciformis and Medicago turbinata.
    Bird GW; Wingham J
    J Clin Pathol; 1983 Feb; 36(2):195-6. PubMed ID: 6826775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does red-cell T activation matter?
    Eder AF; Manno CS
    Br J Haematol; 2001 Jul; 114(1):25-30. PubMed ID: 11472340
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometric analysis of erythrocyte populations in Tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen.
    Bigbee WL; Langlois RG; Stanker LH; Vanderlaan M; Jensen RH
    Cytometry; 1990; 11(2):261-71. PubMed ID: 1690628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the Tn antigen in leukaemia using monoclonal anti-Tn antibody and immunohistochemistry.
    Roxby DJ; Morley AA; Burpee M
    Br J Haematol; 1987 Oct; 67(2):153-6. PubMed ID: 3479188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical studies on the differential binding properties of two monoclonal antibodies reacting with Tn red cells.
    King MJ; Parsons SF; Wu AM; Jones N
    Transfusion; 1991 Feb; 31(2):142-9. PubMed ID: 1847560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An example of polyagglutinability due to the Tn antigen.
    Gunson HH; Stratton F; Mullard GW
    Br J Haematol; 1970 Mar; 18(3):309-16. PubMed ID: 5491583
    [No Abstract]   [Full Text] [Related]  

  • 13. Tn-polyagglutinability of red blood cells and acquired A-like specificity.
    Kourteva BT; Manolova VR; Mitova DK
    Transfusion; 1977; 17(3):272-6. PubMed ID: 867471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono- and poly-clonal anti-Tn antibodies induced by various immunogens.
    Springer GF; Chandrasekaran EV; Desai PR; Tegtmeyer H
    Carbohydr Res; 1988 Jul; 178():271-92. PubMed ID: 3056614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
    King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
    Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T and Tk transformation in hemolytic uremic syndromes.
    Lynen R; Neumeyer H; Schulte B; Rumpf KW; Martell J
    Beitr Infusionsther; 1990; 26():409-11. PubMed ID: 1703887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tn-syndrome.
    Berger EG
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):255-68. PubMed ID: 10571017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of normal red blood cells to become Tn-activated when transfused into a patient with Tn-polyagglutination.
    Reid ME; Ellisor SS; Swanson J; Edwards G; Stanik F
    Am J Med Technol; 1980 Sep; 46(9):670-2. PubMed ID: 7416196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-field polyagglutinability due to tn: a further example.
    Moore BP; Marsh S; Laschinger C; Simpson S
    Transfusion; 1975; 15(1):54-7. PubMed ID: 1114514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.